<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2016</study_start_year><condition>colorectal cancer</condition><disease>Colorectal Cancer</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2667270</full_dataset_link><location>China</location><study_start_month>10</study_start_month><repository>ECRIN MDR</repository><study_status>Recruiting</study_status></additional><is_claimable>false</is_claimable><name>The prolonged adjuvant therapy with capecitabine after R0 surgery and perioperative chemotherapy for advanced colorectal cancer with only liver metastasis: a prospective, multicenter, randomized, controlled clinical study.</name><description>Interventions: control group:observation;study group:Capecitabine
Primary outcome(s): DFS
Study Design: Randomized parallel controlled trial</description><dates><creation>2016-10-15</creation></dates><accession>2667270</accession><cross_references><Chinese Clinical Trial Register>ChiCTR-IPR-16009755</Chinese Clinical Trial Register></cross_references></HashMap>